Tuesday, December 27, 2016

BRIEF-Sucampo Pharmaceuticals say issued $300 mln of convertible senior notes due 2021 - SEC filing

* Sucampo Pharmaceuticals Inc - notes were issued to Leerink

Partners LLC

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)